Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of YZJT-1705 injection for postoperative analgesia after abdominal surgery
CTR20263580Phase 2Active
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YZJT-1705 in postoperative pain, sponsored by Shanghai Institute of Materia Medica. Started Sep 2026; status: active.
02
Drugs
YZJT-1705
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20263580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263580.